Table 1 Clinical characteristics of influenza patients and healthy controls.

From: Metabolomic and clinical feature analyses of plasma from influenza A patients

Characteristics

Healthy control(n = 20)

Influenza group

Mild(n = 20)

Severe(n = 20)

Critical(n = 14)

Basic characteristics

Gender

Male, male

9(45.00)

10(50.00)

12(60.00)

9(64.29)

Women, women

11(55.00)

10(50.00)

8(40.00)

5(35.71)

Thermal history, day

3.00(2.00, 3.00)b

4.00(3.00, 7.00)

3.0, 0(2.00, 5.50)

Highest temperature, °C

39.00(38.53, 39.28)

39.00(38.50, 39.47)

39.00(38.05, 39.80)

Blood routine test

WBC,×10^9/L

6.42(5.24, 7.05)

6.95(4.77, 7.53)

6.16(4.95, 7.66)

7.48(4.39, 8.85)

HB, g/L

144.50(132.5, 161.00)

149.00(141.00, 157.00)

136.50(123.75, 136.50)

130.00(105.00, 132.00)

PLT ×10^9/L

277.50(190.25, 267.50)a

224.00(218.00, 259.00)b

180.00(144.50, 211.00)

134.00(90.00, 260.00)

Neu count, ×10^9/L

3.67(2.68, 4.24)a

4.24(2.65, 5.59)

4.55(3.11, 5.72)

4.62(3.77, 6.39)

Mon count, ×10^9/L

0.34(0.28, 0.49)a

0.78(0.67, 0.85)b

0.54(0.35, 0.62)

0.22(0.20, 0.79)

Lym count, ×10^9/L

2.09(1.93, 2.45)a

1.27(0.95, 1.36)

1.22(0.81, 1.77)

0.58(0.42, 1.17)

C-reactive protein, mg/L

15.30(3.82, 32.44)a

37.20(15.40, 84.90)b

90.04(51.72, 90.04)

55.60(22.40, 92.80)

Liver biochemical indicators

Total bilirubin, µmol/L

16.55(12.38, 18.58)

10.30(7.20, 15.90)

8.10(6.60, 17.03)

9.10(6.90, 15.30)

Direct bilirubin, µmol/L

4.74(3.60, 5.57)

2.90(2.11, 4.38)

3.00(2.07, 7.28)

2.90(1.63, 5.80)

ALT, U/L

20.00(15.25, 29.50)

21.70(14.00, 42.00)

21.00(12.10, 46.50)

31.00(14.00, 45.00)

AST, U/L

22.50(18.40, 32.75)a

25.00(19.00, 49.00)

36.30(23.60, 60.25)

48.50(29.00, 52.00)

Albumin, g/L

39.40(37.50, 43.38)a

35.50(29.70, 36.70)

33.60(29.00, 37.48)

33.10(29.70, 38.20)

Globulin, g/L

27.85(24.23, 33.33)

28.20(25.70, 30.10)

27.05(22.95, 29.73)

28.90(25.50, 30.80)

ALP, U/L

60.00(52.25, 89.00)a

76.00(53.00, 89.00)

89.50(74.00, 118.25)

87.00(56.00, 92.00)

Myocardial enzyme spectrum indicators

LDH, U/L

182.50(157.50, 229.50)a

237.00(174.00, 323.00)

311.00(207.75, 423.75)

323.00(237.00, 411.00)

CK, U/L

67.50(48.00, 109.00)

68.00(37.00, 225.00)b

70.00(42.25, 176.75)

83.00(28.00, 113.00)

CK-MB, U/L

12.00(9.83, 13.00)a

15.00(9.10, 18.00)

14.00(12.00, 24.70)

15.00(9.00, 24.00)

Indicators of renal function

Urea, µmol/L

4.85(4.00, 5.75)

4.80(3.40, 6.40)

6.20(5.13, 7.70)

5.00(3.70, 6.10)

Creatinine, µmol/L

58.65(45.00, 69.32)

63.21(51.00, 72.30)

51.50(42.50, 91.94)

47.11(43.95, 54.80)

Electrolyte

Sodium ion, mmol/L

141.25(139.65, 142.85)a

138.00(135.70, 140.10)

139.40(137.08, 142.00)

136.80(135.00, 138.30)

Potassium ion, mmol/L

3.90(3.73, 3.90)

3.80(3.60, 4.60)

3.97(3.81, 4.17)

3.80(3.60, 4.40)

Calcium ion, mmol/L

2.17(2.10, 2.20)a

2.09(1.99, 2.19)

2.02(1.93, 2.17)

2.09(1.92, 2.19)

Phosphorus ion, mmol/L

1.08(1.01, 1.11)a

1.02(0.80, 1.14)

0.85(0.71, 1.08)

0.84(0.62, 1.01)

  1. Data are expressed as the median (quartile) or n (%). a (P < 0.05), patients in the control group were compared with influenza patients; b (P < 0.05), among influenza patients, mild patients were compared with severe/critical patients. Comorbidity was defined as the presence of at least one chronic condition, including cardiovascular disease, chronic respiratory disease, diabetes, or immunosuppression.